BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18034409)

  • 1. [Health-care costs and health technology assessment].
    Lettieri E; Masella C
    G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The death of cost-minimization analysis?
    Briggs AH; O'Brien BJ
    Health Econ; 2001 Mar; 10(2):179-84. PubMed ID: 11252048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cost-effectiveness analysis in health care decision-making.
    Magel JS
    Physician Exec; 1990; 16(3):31-2. PubMed ID: 10113233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology assessment in medicine: methods, status and trends.
    Hendee WR
    Med Prog Technol; 1991; 17(2):69-75. PubMed ID: 1835752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indirect costs in health technology assessment].
    Jakubczyk M; Wrona W; Macioch T; Golicki D; Niewada M; Hermanowski T
    Pol Merkur Lekarski; 2010 Jan; 28(163):42-5. PubMed ID: 20369723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care technology: how can we tell if we can afford it? A Canadian viewpoint.
    Dolan A; Zingg W
    J Long Term Eff Med Implants; 1993; 3(4):277-82. PubMed ID: 10146729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment in oral health.
    Esfandiari S; Feine J
    Int J Oral Maxillofac Implants; 2011; 26 Suppl():93-100; discussion 101-2. PubMed ID: 21465002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding health technology assessment.
    Craig AM
    Med Device Technol; 2000 Sep; 11(7):32-7. PubMed ID: 15326744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical context of technology assessment.
    Smits HL
    J Health Polit Policy Law; 1984; 9(l):31-40. PubMed ID: 11650667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis as a measure of value.
    Garber AM
    Tecnologica; 1996 Jan; ():1, 3-6, 9-10. PubMed ID: 10170483
    [No Abstract]   [Full Text] [Related]  

  • 14. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology assessment and the doctor-patient relationship.
    Wax AL
    Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567
    [No Abstract]   [Full Text] [Related]  

  • 16. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment: an evidence-based medicine perspective.
    Glasziou P
    Med Decis Making; 2012; 32(1):E20-4. PubMed ID: 22040831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sounding Boards. What is CBA/CEA, and why are they doing this to us?
    Fuchs VR
    N Engl J Med; 1980 Oct; 303(16):937-8. PubMed ID: 6774250
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of regional data. Costs vs. benefits of ALS.
    Scheib BT
    JEMS; 1983 Jan; 8(1):79-82. PubMed ID: 10309829
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review.
    Gallego G; Harris A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):615-7. PubMed ID: 21155692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.